Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
2.730
-0.100 (-3.53%)
Nov 22, 2024, 4:00 PM EST - Market closed
MBRX's stock price has decreased by -65.15% in the past year and price targets may not have had time to catch up.

Moleculin Biotech Analyst Ratings

Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$31.00
Upside
+1,035.53%

Ratings History

Analyst Firm Rating Rating Action Price Target Upside Date
Maxim Group
Maxim Group
Strong Buy
Maintains
$20$8
Strong Buy Maintains $20$8 +193.04% Nov 12, 2024
Roth MKM
Roth MKM
Strong Buy
Maintains
$40
Strong Buy Maintains $40 +1,365.20% Apr 12, 2024
Maxim Group
Maxim Group
Strong Buy
Maintains
$45$20
Strong Buy Maintains $45$20 +632.60% Mar 26, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$45
Strong Buy Initiates $45 +1,548.35% Dec 14, 2023
Roth MKM
Roth MKM
Strong Buy
Maintains
$240
Strong Buy Maintains $240 +8,691.21% Apr 18, 2023
Oppenheimer
Oppenheimer
Buy
Reiterates
$75
Buy Reiterates $75 +2,647.25% Mar 24, 2023
Oppenheimer
Oppenheimer
Buy
Initiates
$30$210
Buy Initiates $30$210 +7,592.31% Jul 18, 2022